Member
AdventHealth 鈥 Altamonte Springs, Fla.
Rebranding Initiative Propelled AdventHealth to Provide Consumers More Price Transparency
The AHA鈥檚 Members in Action series highlights how hospitals and health systems are implementing new value-based strategies to improve health care affordability. This鈥
Patients have many questions when planning for their care. An important one is: How much is this going to cost me?
The AHA Wednesday, Nov. 4, at 4 p.m. ET will host a special live virtual event where AHA President and CEO Rick Pollack and Executive Vice President of Government Relations and Public Policy Tom Nickels will break down the election results and what they may mean for health care.
Please contact your representatives today and ask them to sign onto a bipartisan 鈥淒ear Colleague鈥 letter to Department of Health and Human Services Secretary Alex Azar expressing concern about recent efforts by Kalderos to transition the 340B Drug Pricing Program from one of up-front discounts to鈥
The Department of Health and Human Services (HHS) today posted reports on its
Please contact your senators and representatives and urge them to eliminate the $4 billion in Medicaid DSH cuts for the next fiscal year. More details follow on the FY 2021 DSH cuts and services that Medicaid DSH hospitals provide nationally.
The Medicaid Disproportionate Share Hospital (DSH) program provides financial assistance to hospitals serving a disproportionate number of low-income patients and thereby ensures that Medicaid and uninsured patients have access to health care services.
Please contact your representatives today and ask them to sign onto a bipartisan 鈥淒ear Colleague鈥 letter to Department of Health and Human Services Secretary Alex Azar expressing concern about recent efforts by Kalderos to transition the 340B Drug Pricing Program from one of up-front discounts to鈥
Please contact your representatives today and ask them to sign onto a bipartisan 鈥淒ear Colleague鈥 letter to Department of Health and Human Services Secretary Alex Azar expressing concern about recent efforts by Kalderos to transition the 340B Drug Pricing Program from one of up-front discounts to鈥